Literature DB >> 22403185

Impaired neurotransmission in ether lipid-deficient nerve terminals.

Alexander Brodde1, Andre Teigler, Britta Brugger, Wolf D Lehmann, Felix Wieland, Johannes Berger, Wilhelm W Just.   

Abstract

Isolated defects of ether lipid (EL) biosynthesis in humans cause rhizomelic chondrodysplasia punctata type 2 and type 3, serious peroxisomal disorders. Using a previously described mouse model [Rodemer, C., Thai, T.P., Brugger, B., Kaercher, T., Werner, H., Nave, K.A., Wieland, F., Gorgas, K., and Just, W.W. (2003) Inactivation of ether lipid biosynthesis causes male infertility, defects in eye development and optic nerve hypoplasia in mice. Hum. Mol. Genet., 12, 1881-1895], we investigated the effect of EL deficiency in isolated murine nerve terminals (synaptosomes) on the pre-synaptic release of the neurotransmitters (NTs) glutamate and acetylcholine. Both Ca(2+)-dependent exocytosis and Ca(2+)-independent efflux of the transmitters were affected. EL-deficient synaptosomes respire at a reduced rate and exhibit a lowered adenosin-5'-triphosphate/adenosine diphosphate (ATP/ADP) ratio. Consequently, ATP-driven processes, such as synaptic vesicle cycling and maintenance of Na(+), K(+) and Ca(2+) homeostasis, might be disturbed. Analyzing reactive oxygen species in EL-deficient neural and non-neural tissues revealed that plasmalogens (PLs), the most abundant EL species in mammalian central nervous system, considerably contribute to the generation of the lipid peroxidation product malondialdehyde. Although EL-deficient tissue contains less lipid peroxidation products, fibroblasts lacking ELs are more susceptible to induced oxidative stress. In summary, these results suggest that due to the reduced energy state of EL-deficient tissue, the Ca(2+)-independent efflux of NTs increases while the Ca(2+)-dependent release declines. Furthermore, lack of PLs is mainly compensated for by an increase in the concentration of phosphatidylethanolamine and results in a significantly lowered level of lipid peroxidation products in the brain cortex and cerebellum.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22403185      PMCID: PMC4880048          DOI: 10.1093/hmg/dds097

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  76 in total

1.  Plasmalogens: targets for oxidants and major lipophilic antioxidants.

Authors:  B Engelmann
Journal:  Biochem Soc Trans       Date:  2004-02       Impact factor: 5.407

2.  Theory of self-assembly of lipid bilayers and vesicles.

Authors:  J N Israelachvili; D J Mitchell; B W Ninham
Journal:  Biochim Biophys Acta       Date:  1977-10-17

3.  Determination of protein: a modification of the Lowry method that gives a linear photometric response.

Authors:  E F Hartree
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

4.  Transmitter glutamate release from isolated nerve terminals: evidence for biphasic release and triggering by localized Ca2+.

Authors:  H T McMahon; D G Nicholls
Journal:  J Neurochem       Date:  1991-01       Impact factor: 5.372

Review 5.  New views of glutamate transporter structure and function: advances and challenges.

Authors:  Jie Jiang; Susan G Amara
Journal:  Neuropharmacology       Date:  2010-08-12       Impact factor: 5.250

6.  SNAREs are concentrated in cholesterol-dependent clusters that define docking and fusion sites for exocytosis.

Authors:  T Lang; D Bruns; D Wenzel; D Riedel; P Holroyd; C Thiele; R Jahn
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

7.  Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry.

Authors:  B Brügger; G Erben; R Sandhoff; F T Wieland; W D Lehmann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

8.  Armet, a UPR-upregulated protein, inhibits cell proliferation and ER stress-induced cell death.

Authors:  Andria Apostolou; Yuxian Shen; Yan Liang; Jun Luo; Shengyun Fang
Journal:  Exp Cell Res       Date:  2008-05-13       Impact factor: 3.905

Review 9.  Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation.

Authors:  Takao Shimizu
Journal:  Annu Rev Pharmacol Toxicol       Date:  2009       Impact factor: 13.820

10.  Synaptotagmin I: a major Ca2+ sensor for transmitter release at a central synapse.

Authors:  M Geppert; Y Goda; R E Hammer; C Li; T W Rosahl; C F Stevens; T C Südhof
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

View more
  24 in total

1.  Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau.

Authors:  Mitchel A Kling; Dayan B Goodenowe; Vijitha Senanayake; Siamak MahmoudianDehkordi; Matthias Arnold; Tyler J Massaro; Rebecca Baillie; Xianlin Han; Yuk-Yee Leung; Andrew J Saykin; Kwangsik Nho; Alexandra Kueider-Paisley; Jessica D Tenenbaum; Li-San Wang; Leslie M Shaw; John Q Trojanowski; Rima F Kaddurah-Daouk
Journal:  Alzheimers Dement       Date:  2020-07-27       Impact factor: 21.566

Review 2.  Peroxisomal Dysfunction in Age-Related Diseases.

Authors:  Cynthia M Cipolla; Irfan J Lodhi
Journal:  Trends Endocrinol Metab       Date:  2017-01-04       Impact factor: 12.015

Review 3.  Peroxisomal Dysfunction and Oxidative Stress in Neurodegenerative Disease: A Bidirectional Crosstalk.

Authors:  Marc Fransen; Iulia Revenco; Hongli Li; Cláudio F Costa; Celien Lismont; Paul P Van Veldhoven
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 4.  Plasmalogens and fatty alcohols in rhizomelic chondrodysplasia punctata and Sjögren-Larsson syndrome.

Authors:  Ana R Malheiro; Tiago Ferreira da Silva; Pedro Brites
Journal:  J Inherit Metab Dis       Date:  2014-11-29       Impact factor: 4.982

5.  How Do Ethanolamine Plasmalogens Contribute to Order and Structure of Neurological Membranes?

Authors:  Ana West; Valeria Zoni; Walter E Teague; Alison N Leonard; Stefano Vanni; Klaus Gawrisch; Stephanie Tristram-Nagle; Jonathan N Sachs; Jeffery B Klauda
Journal:  J Phys Chem B       Date:  2020-01-22       Impact factor: 2.991

6.  The glycosomal alkyl-dihydroxyacetonephosphate synthase TbADS is essential for the synthesis of ether glycerophospholipids in procyclic trypanosomes.

Authors:  Sungsu Lee; Melanie Cheung-See-Kit; Tyler A Williams; Nader Yamout; Rachel Zufferey
Journal:  Exp Parasitol       Date:  2018-02       Impact factor: 2.011

Review 7.  Roles of endogenous ether lipids and associated PUFAs in the regulation of ion channels and their relevance for disease.

Authors:  Delphine Fontaine; Sandy Figiel; Romain Félix; Sana Kouba; Gaëlle Fromont; Karine Mahéo; Marie Potier-Cartereau; Aurélie Chantôme; Christophe Vandier
Journal:  J Lipid Res       Date:  2020-04-07       Impact factor: 5.922

Review 8.  From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system.

Authors:  Fabian Dorninger; Sonja Forss-Petter; Johannes Berger
Journal:  FEBS Lett       Date:  2017-09-07       Impact factor: 4.124

9.  AGMO Inhibitor Reduces 3T3-L1 Adipogenesis.

Authors:  Caroline Fischer; Annett Wilken-Schmitz; Victor Hernandez-Olmos; Ewgenij Proschak; Holger Stark; Ingrid Fleming; Andreas Weigert; Manuela Thurn; Martine Hofmann; Ernst R Werner; Gerd Geisslinger; Ellen Niederberger; Katrin Watschinger; Irmgard Tegeder
Journal:  Cells       Date:  2021-05-01       Impact factor: 7.666

Review 10.  Reappraisal of metabolic dysfunction in neurodegeneration: Focus on mitochondrial function and calcium signaling.

Authors:  Pooja Jadiya; Joanne F Garbincius; John W Elrod
Journal:  Acta Neuropathol Commun       Date:  2021-07-07       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.